Abstract
As transcatheter mitral replacement technologies have recently been applied in early clinical trials, the question as to whether valve implantation would have the potential to become the leading percutaneous mitral valve therapy has been raised. The aim of this report is to give an overview of the different peculiarities of percutaneous replacement and repair techniques, and to predict whether the two approaches will have a complementary rather than a competitive clinical role in the near future.
MeSH terms
-
Cardiac Catheterization / adverse effects
-
Cardiac Catheterization / instrumentation*
-
Cardiac Catheterization / methods
-
Heart Valve Prosthesis Implantation / adverse effects
-
Heart Valve Prosthesis Implantation / instrumentation*
-
Heart Valve Prosthesis Implantation / methods
-
Heart Valve Prosthesis*
-
Humans
-
Mitral Valve / diagnostic imaging
-
Mitral Valve / physiopathology
-
Mitral Valve / surgery*
-
Mitral Valve Annuloplasty / adverse effects
-
Mitral Valve Annuloplasty / instrumentation*
-
Mitral Valve Annuloplasty / methods
-
Mitral Valve Insufficiency / diagnostic imaging
-
Mitral Valve Insufficiency / physiopathology
-
Mitral Valve Insufficiency / surgery*
-
Mitral Valve Stenosis / diagnostic imaging
-
Mitral Valve Stenosis / physiopathology
-
Mitral Valve Stenosis / surgery*
-
Patient Selection
-
Prosthesis Design
-
Prosthesis Failure
-
Risk Factors
-
Severity of Illness Index
-
Treatment Outcome